Cannabis Use Disorder clinical trials
38 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Longitudinal Outpatient Treatment for Cannabis Use Disorder
- RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
- Cannabis-Tobacco Co-Use Treatment Study
- Evaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
- Psilocybin-assisted Treatment for Cannabis Use Disorder
- SCORE Emerging Adult Cannabis Use & Stress
- Integrated Treatment for Enhancing Growth in Recovery During Adolescence
- Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
- Neuroimaging of Adolescent Cannabis Use Treatment
- Cannabis Reduction and Functional Outcomes
- Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
- Mitigating PTSD-CUD After Sexual Assault
- A Brief Intervention for Cannabis Use
- Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users
- Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
- Study of Oral Fluid Testing Approach
- SV2 PET Imaging With [11C]APP311
- Cannabis and Processing Emotions Study
- SV2A Density Cannabis Use Disorder
- Sex Differences in Neurobehavioral Response to THC
- Effects of THC on Alcohol Consumption and Neural Correlates of Reward
- A Study of Cannabidiol in Young Adult Cannabis Users
- Cannabidiol and Cannabis Concentrate Users
- Determining the Effect of Six Weeks of Cannabis Abstinence on Fronto- Striatal fMRI Markers in Adolescents With Cannabis Use Disorder (ABSCAN)
- High Potency Cannabis: Acute and Protracted Effects
- Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
- Cannabinoids and Biological Reactivity to Stress
- Stress and Pain in People Living With HIV
- Cannabis, Linked Emotions, and Adolescent Risk Study
- The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
- Skills for Talking About Cannabis for Families of Young Adults With Psychosis
- Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
- Applying Mixed Methods to Identify Links Between PTSD Symptoms, Cannabis Use, and Functional Behaviors With Personalized Feedback Intervention Development
- Pregnenolone for Cannabis Use Disorder and Depression
- Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder
- QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
- Developing a Telehealth + mHealth Cannabis Use Intervention for Young Adults
- Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cannabis Use Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.